|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/10 | (2006.01) |
| C07D 487/20 | (2006.01) | ||
| C07D 498/22 | (2006.01) | ||
| A61K 31/553 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3183254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15751029.8 |
| Date of filing the European patent application | 2015-08-20 | |
| (97) | Date of publication of the European application | 2017-06-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation | 2019-08-26 |
| (86) | Number | PCT/EP2015/069174 |
| Date | 2015-08-20 |
| (87) | Number | WO 2016/026937 |
| Date | 2016-02-25 |
| (30) | Number | Date | Country code |
| 14181746 | 2014-08-21 | EP |
| (72) |
RAMHARTER, Juergen, DE
BROEKER, Joachim, DE
GILLE, Annika, DE
GOLLNER, Andreas, DE
HENRY, Manuel, DE
TOELLE, Nina, DE
WEINSTABL, Harald, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujieji spiro[3H-indol-3,2' -pirolidin]-2(1H)-ono junginiai ir dariniai, kaip MDM2-p53 inhibitoriai |
| NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 11 | 289.00 EUR |
| 2026-08-20 |